G. Varuni Kondagunta

Combination of Paclitaxel, Ifosfamide, and Cisplatin Is an Effective Second-Line Therapy for Patients With Relapsed Testicular Germ Cell Tumors

G. Varuni Kondagunta, Jennifer Bacik, Alessia Donadio et al. · Journal of Clinical Oncology · 2005 · 415 citations · Full text

Medicine, Oncology, Chemotherapy +15

Phase II Trial of Bortezomib for Patients With Advanced Renal Cell Carcinoma

G. Varuni Kondagunta, Beverly J. Drucker, Lawrence Schwartz et al. · Journal of Clinical Oncology · 2004 · 193 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

A phase II trial of 17-(Allylamino)-17-demethoxygeldanamycin in patients with papillary and clear cell renal cell carcinoma

Ellen A. Ronnen, G. Varuni Kondagunta, Nicole Ishill et al. · Investigational New Drugs · 2006 · 148 citations

Medicine, Oncology, Pharmacology +9

Paclitaxel Plus Ifosfamide Followed by High-Dose Carboplatin Plus Etoposide in Previously Treated Germ Cell Tumors

G. Varuni Kondagunta, Jennifer Bacik, Joel Sheinfeld et al. · Journal of Clinical Oncology · 2006 · 136 citations

Medicine, Oncology, Surgery +16

Clinical Outcome and Predictors of Survival in Late Relapse of Germ Cell Tumor

David S. Sharp, Brett S. Carver, Scott E. Eggener et al. · Journal of Clinical Oncology · 2008 · 116 citations

Medicine, Oncology, Surgery +9